Methylprednisolone Completed Phase 3 Trials for Glomerulonephritis membranous Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01955187Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy